- FDA Recommends Moderna COVID Vaccine Booster.
- Originally, the Moderna vaccine was effective with a single dose… that changed.
- Risk groups are the ones that should receive it first.
The FDA (Food and Drug Administration) of the United States, made up of health experts, issued a recommendation for the population at risk, that is, the elderly, to be the first to get another booster dose of the Moderna COVID vaccine.
Older people and those with chronic diseases are the first to be considered for another dose of the Moderna vaccine according to the FDA recommendation amid numbers of coronavirus infections that continue to rise worldwide, despite vaccines of several companies being applied.
FDA recommends another dose of Modern COVID vaccine
According to reports from AP, replicated by other media such as ‘El Universal’, it was reported that the FDA issued this recommendation on Thursday as it did at some point months ago with the one corresponding to the dose of Pfizer, which has been so far the most applied vaccine in all the world.
The third dose of Pfizer’s vaccine has already been authorized since the end of September and has been applied to risk sectors such as the elderly and patients with chronic degenerative diseases for weeks; however the FDA is about to approve another extra dose of another vaccine.
Modern COVID Vaccine Will Require Extra Dose, FDA Says
The FDA committee that approved the extra dose of the Moderna vaccine will debate this Friday whether a recommendation will also be issued for an extra Johnson & Johnson vaccine in the midst of the coronavirus pandemic whose wave intensified in 2021 due to the variant delta.
Meanwhile, it was reported that the extra dose of the Modern vaccine against COVID is recommended for people over 65 years of age, adults who due to their age condition are more likely to fall into a severe disease, in addition to workers who are more exposed to get infected again.
FDA recommends extra dose of Modern COVID vaccine
According to AP reports, around seven million people living in the US have received the third dose against COVID, of which three million correspond to the previous week, according to data provided by the Casa’s pandemic response team. White.
For its part, the Joe Biden government extends its trust in the FDA and the recommendations it is issuing to safeguard the health of the population, as well as the work of the Centers for Disease Control (CDC), which is expected to they also approve boosters in vaccines from Moderna and Johnson & Johnson.
66 million Americans to be vaccinated
Despite the good news of the acceleration in the application of vaccines in the United States, the government of Joe Biden recognized that there are still 66 million Americans who have not been vaccinated, which it called as ‘unacceptable’, although that is already its own decision, despite that several organizations and companies have ‘threatened’ their staff with consequences if they do not prove that they have the vaccination scheme.
In his most recent public appearance, US President Joe Biden said that so far the country has dropped by 47 percent the cases of people infected by COVID, also specifying only 38 percent of patients who tested positive for the coronavirus in the last month and a half.
FDA Reviews More Recommendations for Other COVID Vaccines
VACCINES FOR CHILDREN. The White House reveals when children over 5 years of age could begin to vaccinate across the country and has asked local leaders to prepare for an early vaccination operation for minors.
This Tuesday, the working group on the coronavirus of the government of President Joe Biden invited the states to prepare a plan to begin implementing vaccines against COVID-19 in children in the coming weeks.
White House reveals when children could start vaccinating
The team working for the White House told governors that school-age children could be eligible for vaccines by early November, prompting them to design an immunization plan for them, said a source who participated. in the call between local leaders and specialists.
Jeff Zients, coordinator of response to the pandemic, assured that the White House would have available the necessary materials for the vaccination of some 28 million children between 5 and 11 years old throughout the United States, as reported The Hill.
Pfizer requested FDA approval
Last week, Pfizer announced that it had asked the Food and Drug Administration (FDA) for authorization to apply its vaccine in children between 5 and 11 years old and this October 26 an advisory committee of the organization will meet to discuss the issue.
“UPDATE: We and @BioNTech_Group officially present our request to @US_FDA for the Emergency Use Authorization (USA) of our # COVID19 vaccine in children 5 to <12 years old,” the pharmacist wrote on her Twitter account. Filed Under: FDA Modern COVID Vaccine.
The White House is already preparing
On Wednesday, Jen Psaki, the White House press secretary, said the government is already preparing to release all information regarding the vaccination of children as soon as it is approved, including the sites available to apply the doses and any concerns they may have. parents.
“Parents will want to go and ask their doctor questions, ask their pediatrician questions, better understand the safety and efficacy of the vaccine,” said the spokesperson, so they hope to “empower local medical experts, pediatricians, doctors to That they can talk about it, that they can answer any questions they have. We will encourage people to talk to their doctors. ” Filed Under: FDA Modern COVID Vaccine.
Vaccines approved for children 12 years and older
In May, the White House announced that children over the age of 12 were eligible for Pfizer’s vaccine against Covid-19. Now, at the end of September, he released the positive results his studies had obtained in younger children, which yielded a “favorable safety profile and strong neutralizing antibody responses.”
In fact, Pfizer has tested children at a dose that contains one-third the amount they have used for adults and it has still been found to be effective. Although the dose is lower, it recommends vaccination to protect the little ones from the virus as well. Filed Under: FDA Modern COVID Vaccine.
Covid-19 in young children
Statistics show that children get less sick from COVID-19 than older people and that their symptoms are less severe, but that does not exempt them from the risk of becoming infected.
According to the American Academy of Pediatrics, during the week ending September 30, almost 175,000 cases were registered in children and it is because the highly transmissible delta variant has driven the increase in the number of cases. White House reveals when children could start vaccinating. Filed Under: FDA Modern COVID Vaccine.
The post FDA issues recommendation of another dose of the ‘Moderna’ vaccine for sectors at risk appeared first on Hispanic World.